Clinical Trial Update: Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of sublingual immunotherapy (SLIT) for rhinitis and rhinoconjunctivitis due to dust mites, with or wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinitis
• Rhinoconjunctivitis

Drugs mentioned

• Sublingual immunotherapy (SLIT) (Sublingual immunotherapy)

Snippet

Sponsor: Inmunotek S.L. | Conditions: Rhinitis, Rhinoconjunctivitis | Phase 3 | Status: RECRUITING